These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 19887605

  • 1. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.
    Kawakami K, Hirata H, Yamamura S, Kikuno N, Saini S, Majid S, Tanaka Y, Kawamoto K, Enokida H, Nakagawa M, Dahiya R.
    Cancer Res; 2009 Nov 15; 69(22):8603-10. PubMed ID: 19887605
    [Abstract] [Full Text] [Related]

  • 2. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
    Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y.
    Oncogene; 2005 Nov 24; 24(53):7946-52. PubMed ID: 16007117
    [Abstract] [Full Text] [Related]

  • 3. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S, Shiina H, Enokida H, Hirata H, Kawamoto K, Kawakami T, Kikuno N, Tanaka Y, Majid S, Nakagawa M, Igawa M, Dahiya R.
    Clin Cancer Res; 2006 Dec 01; 12(23):6989-97. PubMed ID: 17145819
    [Abstract] [Full Text] [Related]

  • 4. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.
    Gao Z, Xu Z, Hung MS, Lin YC, Wang T, Gong M, Zhi X, Jablon DM, You L.
    Anticancer Res; 2009 Jun 01; 29(6):2025-30. PubMed ID: 19528461
    [Abstract] [Full Text] [Related]

  • 5. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.
    Ueno K, Hirata H, Majid S, Chen Y, Zaman MS, Tabatabai ZL, Hinoda Y, Dahiya R.
    Mol Carcinog; 2011 Jun 01; 50(6):449-57. PubMed ID: 21268126
    [Abstract] [Full Text] [Related]

  • 6. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA, Terashima M, Kikuno N, Adachi H, Yoneda T, Kishi H, Shigeno K, Konety BR, Igawa M, Dahiya R.
    Clin Cancer Res; 2006 Jan 15; 12(2):383-91. PubMed ID: 16428476
    [Abstract] [Full Text] [Related]

  • 7. Role of secreted frizzled-related protein 3 in human renal cell carcinoma.
    Hirata H, Hinoda Y, Ueno K, Majid S, Saini S, Dahiya R.
    Cancer Res; 2010 Mar 01; 70(5):1896-905. PubMed ID: 20160027
    [Abstract] [Full Text] [Related]

  • 8. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
    Hu J, Dong A, Fernandez-Ruiz V, Shan J, Kawa M, Martínez-Ansó E, Prieto J, Qian C.
    Cancer Res; 2009 Sep 01; 69(17):6951-9. PubMed ID: 19690140
    [Abstract] [Full Text] [Related]

  • 9. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I, Thavathiru E, Ramalingam S, Natarajan G, Mills WK, Benbrook DM, Zuna R, Lightfoot S, Reis A, Anant S, Queimado L.
    Oncogene; 2012 May 31; 31(22):2725-37. PubMed ID: 22002305
    [Abstract] [Full Text] [Related]

  • 10. Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma.
    Okuda H, Toyota M, Ishida W, Furihata M, Tsuchiya M, Kamada M, Tokino T, Shuin T.
    Oncogene; 2006 Mar 16; 25(12):1733-42. PubMed ID: 16278676
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.
    Zhang T, Zheng J, Jiang N, Wang G, Shi Q, Liu C, Lu Y.
    Cancer Lett; 2009 Sep 28; 283(1):59-67. PubMed ID: 19380190
    [Abstract] [Full Text] [Related]

  • 12. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E, Wiesmann F, Woenckhaus M, Stoehr R, Wild PJ, Veeck J, Knüchel R, Klopocki E, Sauter G, Simon R, Wieland WF, Walter B, Denzinger S, Hartmann A, Hammerschmied CG.
    Oncogene; 2007 Aug 16; 26(38):5680-91. PubMed ID: 17353908
    [Abstract] [Full Text] [Related]

  • 13. Wnt inhibitory factor-1 functions as a tumor suppressor through modulating Wnt/β-catenin signaling in neuroblastoma.
    Zhang J, Zhou B, Liu Y, Chen K, Bao P, Wang Y, Wang J, Zhou Z, Sun X, Li Y.
    Cancer Lett; 2014 Jun 28; 348(1-2):12-9. PubMed ID: 24561119
    [Abstract] [Full Text] [Related]

  • 14. Methylation-associated silencing of SFRP1 in renal cell carcinoma.
    Awakura Y, Nakamura E, Ito N, Kamoto T, Ogawa O.
    Oncol Rep; 2008 Nov 28; 20(5):1257-63. PubMed ID: 18949430
    [Abstract] [Full Text] [Related]

  • 15. Wnt inhibitory factor-1 regulates glioblastoma cell cycle and proliferation.
    Wu J, Fang J, Yang Z, Chen F, Liu J, Wang Y.
    J Clin Neurosci; 2012 Oct 28; 19(10):1428-32. PubMed ID: 22901505
    [Abstract] [Full Text] [Related]

  • 16. Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.
    Lv D, Zhao W, Dong D, Qian XP, Zhang Y, Tian XJ, Zhang J.
    Eur J Cancer; 2011 Sep 28; 47(13):2068-76. PubMed ID: 21600761
    [Abstract] [Full Text] [Related]

  • 17. RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis.
    Peters I, Rehmet K, Wilke N, Kuczyk MA, Hennenlotter J, Eilers T, Machtens S, Jonas U, Serth J.
    Mol Cancer; 2007 Jul 16; 6():49. PubMed ID: 17634119
    [Abstract] [Full Text] [Related]

  • 18. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
    Werner NS, Siprashvili Z, Fong LY, Marquitan G, Schröder JK, Bardenheuer W, Seeber S, Huebner K, Schütte J, Opalka B.
    Cancer Res; 2000 Jun 01; 60(11):2780-5. PubMed ID: 10850413
    [Abstract] [Full Text] [Related]

  • 19. Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas.
    Saini S, Liu J, Yamamura S, Majid S, Kawakami K, Hirata H, Dahiya R.
    Cancer Res; 2009 Sep 01; 69(17):6815-22. PubMed ID: 19723665
    [Abstract] [Full Text] [Related]

  • 20. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
    Morris MR, Gentle D, Abdulrahman M, Maina EN, Gupta K, Banks RE, Wiesener MS, Kishida T, Yao M, Teh B, Latif F, Maher ER.
    Cancer Res; 2005 Jun 01; 65(11):4598-606. PubMed ID: 15930277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.